BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36715610)

  • 1. Long-term survival outcomes after lobe-specific nodal dissection in patients with early non-small-cell lung cancer.
    Kamigaichi A; Aokage K; Ikeno T; Wakabayashi M; Miyoshi T; Tane K; Samejima J; Tsuboi M
    Eur J Cardiothorac Surg; 2023 Feb; 63(2):. PubMed ID: 36715610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lobe-Specific Nodal Dissection for Clinical Stage I and II NSCLC: Japanese Multi-Institutional Retrospective Study Using a Propensity Score Analysis.
    Hishida T; Miyaoka E; Yokoi K; Tsuboi M; Asamura H; Kiura K; Takahashi K; Dosaka-Akita H; Kobayashi H; Date H; Tada H; Okumura M; Yoshino I;
    J Thorac Oncol; 2016 Sep; 11(9):1529-37. PubMed ID: 27249959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lobe-Specific Lymph Node Dissection as a Standard Procedure in Surgery for Non-Small Cell Lung Cancer: A Propensity Score Matching Study.
    Adachi H; Sakamaki K; Nishii T; Yamamoto T; Nagashima T; Ishikawa Y; Ando K; Yamanaka K; Watanabe K; Kumakiri Y; Tsuboi M; Maehara T; Nakayama H; Masuda M
    J Thorac Oncol; 2017 Jan; 12(1):85-93. PubMed ID: 27553515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphadenectomy for clinical early-stage non-small-cell lung cancer: a systematic review and meta-analysis.
    Meng D; Zhou Z; Wang Y; Wang L; Lv W; Hu J
    Eur J Cardiothorac Surg; 2016 Oct; 50(4):597-604. PubMed ID: 27107044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lobe-specific Lymph Node Dissection in Clinical Stage IA Solid-dominant Non-small-cell Lung Cancer: A Propensity Score Matching Study.
    Zhao Y; Mao Y; He J; Gao S; Zhang Z; Ding N; Xue Q; Gao Y; Wang D; Zhao J; Tan F; Yuan L; Li F; Wang S; Yang L
    Clin Lung Cancer; 2021 Mar; 22(2):e201-e210. PubMed ID: 33187913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Permissible Outcomes of Lobe-Specific Lymph Node Dissection for Elevated Carcinoembryonic Antigen in Non-Small Cell Lung Cancer.
    Kuroda H; Ichinose J; Masago K; Takahashi Y; Nakada T; Nakao M; Okumura S; Hashimoto K; Matsuura Y; Sakakura N; Matsushita H; Mun M
    Medicina (Kaunas); 2021 Dec; 57(12):. PubMed ID: 34946309
    [No Abstract]   [Full Text] [Related]  

  • 7. A multicenter propensity score-matched analysis of lymphadenectomy in N1-positve lung cancer.
    Handa Y; Tsutani Y; Mimae T; Miyata Y; Ito H; Shimada Y; Nakayama H; Ikeda N; Okada M
    Jpn J Clin Oncol; 2023 Dec; 53(12):1183-1190. PubMed ID: 37622593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence of mediastinal node cancer after lobe-specific systematic nodal dissection for non-small-cell lung cancer.
    Maniwa T; Okumura T; Isaka M; Nakagawa K; Ohde Y; Kondo H
    Eur J Cardiothorac Surg; 2013 Jul; 44(1):e59-64. PubMed ID: 23644712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lobe-specific nodal dissection with intraoperative frozen section analysis for clinical stage-I non-small cell lung cancer: a validation study by propensity score matching.
    Isaka M; Kojima H; Imai T; Konno H; Mizuno T; Nagata T; Katsumata S; Kawata T; Nakajima T; Ohde Y
    Gen Thorac Cardiovasc Surg; 2022 Nov; 70(11):977-984. PubMed ID: 35543932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extent of removal for mediastinal nodal stations for patients with clinical stage I non-small cell lung cancer: effect on outcome.
    Jeon HW; Moon MH; Kim KS; Kim YD; Wang YP; Park HJ; Park JK
    Thorac Cardiovasc Surg; 2014 Oct; 62(7):599-604. PubMed ID: 24420680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of station 4L lymph node dissection on short-term and long-term outcomes in non-small cell lung cancer.
    Wo Y; Li H; Zhang Y; Peng Y; Wu Z; Liu P; Shang Y; Hu H; Zhang Y; Xiang J; Sun Y
    Lung Cancer; 2022 Aug; 170():141-147. PubMed ID: 35780588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lobe-specific mediastinal nodal dissection is sufficient during lobectomy by video-assisted thoracic surgery or thoracotomy for early-stage lung cancer.
    Shapiro M; Kadakia S; Lim J; Breglio A; Wisnivesky JP; Kaufman A; Lee DS; Flores RM
    Chest; 2013 Nov; 144(5):1615-1621. PubMed ID: 23828253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer.
    Wu Yl; Huang ZF; Wang SY; Yang XN; Ou W
    Lung Cancer; 2002 Apr; 36(1):1-6. PubMed ID: 11891025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lobe-specific lymph node dissection in stage IA non-small-cell lung cancer: a retrospective cohort study.
    Abughararah TZ; Jeong YH; Alabbood F; Chong Y; Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
    Eur J Cardiothorac Surg; 2021 Apr; 59(4):783-790. PubMed ID: 33150427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of mediastinal lymph nodes sampling in patients with clinical stage I non-small cell lung cancer.
    Takizawa H; Kondo K; Matsuoka H; Uyama K; Toba H; Kenzaki K; Sakiyama S; Tangoku A; Miura K; Yoshizawa K; Morita J
    J Med Invest; 2008 Feb; 55(1-2):37-43. PubMed ID: 18319543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery.
    Chang JY; Mehran RJ; Feng L; Verma V; Liao Z; Welsh JW; Lin SH; O'Reilly MS; Jeter MD; Balter PA; McRae SE; Berry D; Heymach JV; Roth JA;
    Lancet Oncol; 2021 Oct; 22(10):1448-1457. PubMed ID: 34529930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extent of mediastinal nodal dissection in stage I non-small cell lung cancer with a radiological pure-solid appearance.
    Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
    Eur J Surg Oncol; 2021 Jul; 47(7):1797-1804. PubMed ID: 33745792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Robotic Approach Offers Similar Nodal Upstaging to Open Lobectomy for Clinical Stage I Non-small Cell Lung Cancer.
    Tang A; Raja S; Bribriesco AC; Raymond DP; Sudarshan M; Murthy SC; Ahmad U
    Ann Thorac Surg; 2020 Aug; 110(2):424-433. PubMed ID: 32240644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thoracoscopic lobectomy is associated with improved short-term and equivalent oncological outcomes compared with open lobectomy for clinical Stage I non-small-cell lung cancer: a propensity-matched analysis of 963 cases.
    Stephens N; Rice D; Correa A; Hoffstetter W; Mehran R; Roth J; Walsh G; Vaporciyan A; Swisher S
    Eur J Cardiothorac Surg; 2014 Oct; 46(4):607-13. PubMed ID: 24603446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.